Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | PDE4A | P27815 | 2/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.30 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21758727 | 0.87 | KCNH2 (0.37) | KCNH2PDE4ADDB1CRBNELANE | |
| SCHEMBL21758181 | 0.87 | CYP11B1 (0.35) | PTGER4 | |
| SCHEMBL21758232 | 0.83 | PTGER4 (0.37) | KCNH2PDE4APTGER4DDB1CRBN | |
| SCHEMBL21758597 | 0.82 | PTGER4 (0.36) | KCNH2PDE4APTGER4DDB1CRBN | |
| SCHEMBL21758233 | 0.82 | PTGER4 (0.37) | PTGER4DDB1CRBNELANE | |
| SCHEMBL21758187 | 0.82 | IDO1 (0.37) | PDE4APTGER4DDB1CRBNELANE | |
| SCHEMBL21758234 | 0.81 | ELANE (0.39) | PTGER4DDB1CRBNELANE | |
| SCHEMBL21758615 | 0.80 | PTGER4 (0.37) | PDE4APTGER4DDB1CRBNELANE | |
| SCHEMBL21758598 | 0.79 | SMO (0.35) | KCNH2PDE4APTGER4DDB1CRBN | |
| SCHEMBL21758191 | 0.78 | IDO1 (0.37) | PDE4ADDB1CRBNELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200062734-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200062734-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OXER1, OR10J3, OXGR1 | KCNH2 1742/4885PDE4A 4878/4885PTGER4 1728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.